請用此 Handle URI 來引用此文件:
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/95096
完整後設資料紀錄
DC 欄位 | 值 | 語言 |
---|---|---|
dc.contributor.advisor | 程藴菁 | zh_TW |
dc.contributor.advisor | Yen-Ching Chen | en |
dc.contributor.author | 顏珮宇 | zh_TW |
dc.contributor.author | Pei-Yu Yen | en |
dc.date.accessioned | 2024-08-28T16:14:45Z | - |
dc.date.available | 2024-08-29 | - |
dc.date.copyright | 2024-08-28 | - |
dc.date.issued | 2024 | - |
dc.date.submitted | 2024-07-30 | - |
dc.identifier.citation | 1. Manly JJ, Jones RN, Langa KM, Ryan LH, Levine DA, McCammon R, Heeringa SG, Weir D: Estimating the prevalence of dementia and mild cognitive impairment in the US: the 2016 Health and Retirement Study harmonized cognitive assessment protocol project. JAMA Neurology 2022, 79(12):1242-1249.
2. Winblad B, Amouyel P, Andrieu S, Ballard C, Brayne C, Brodaty H, Cedazo-Minguez A, Dubois B, Edvardsson D, Feldman H et al: Defeating Alzheimer's disease and other dementias: a priority for European science and society. Lancet Neurology 2016, 15(5):455-532. 3. American Psychiatric Association: Diagnostic and statistical manual of mental disorders: DSM-5™, 5th ed. Arlington, VA, US: American Psychiatric Publishing, Inc.; 2013. 4. Hugo J, Ganguli M: Dementia and cognitive impairment: epidemiology, diagnosis, and treatment. Clinics in Geriatric Medicine 2014, 30(3):421-442. 5. McDade E, Bateman RJ: Stop Alzheimer’s before it starts. Nature 2017, 547(7662):153-155. 6. Chowdhary N, Barbui C, Anstey KJ, Kivipelto M, Barbera M, Peters R, Zheng L, Kulmala J, Stephen R, Ferri CP: Reducing the risk of cognitive decline and dementia: WHO recommendations. Frontiers in neurology 2022, 12:765584. 7. Taiwan Alzheimer’s Disease Association: Dementia population estimation in Taiwan. In. Taiwan Alzheimer’s Disease Association; 2023. 8. Taiwan Ministry of Health and Welfare: Results of the 112-year National Community Dementia Epidemiological Survey. In. Taiwan Ministry of Health and Welfare 2024. 9. You J, Zhang YR, Wang HF, Yang M, Feng JF, Yu JT, Cheng W: Development of a novel dementia risk prediction model in the general population: A large, longitudinal, population-based machine-learning study. Clinical Medicine 2022, 53:101665. 10. Power MC, Mormino E, Soldan A, James BD, Yu L, Armstrong NM, Bangen KJ, Delano-Wood L, Lamar M, Lim YY et al: Combined neuropathological pathways account for age-related risk of dementia. Annals of Neurology 2018, 84(1):10-22. 11. Kivipelto M, Ngandu T, Laatikainen T, Winblad B, Soininen H, Tuomilehto J: Risk score for the prediction of dementia risk in 20 years among middle aged people: a longitudinal, population-based study. Lancet Neurology 2006, 5(9):735-741. 12. Saunders AM, Strittmatter WJ, Schmechel D, George-Hyslop PH, Pericak-Vance MA, Joo SH, Rosi BL, Gusella JF, Crapper-MacLachlan DR, Alberts MJ et al: Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease. Neurology 1993, 43(8):1467-1472. 13. Maner BS, Moosavi L: Mean Corpuscular Volume (MCV). In: StatPearls. edn. Treasure Island (FL); 2020. 14. Jameson J, Fauci AS, Kasper DL, Hauser SL, Longo DL, Loscalzo J: Anemia and Polycythemia. In: Harrison's Manual of Medicine, 20e. edn. New York, NY: McGraw-Hill Education; 2020. 15. Aslinia F, Mazza JJ, Yale SH: Megaloblastic anemia and other causes of macrocytosis. Clinical Medicine Research 2006, 4(3):236-241. 16. Orkin SH, Fisher DE, Ginsburg D, Look AT, Lux SE, Nathan DG: Nathan and Oski's hematology and oncology of infancy and childhood. In., Eighth edn. Philadelphia, PA: Elsevier/Saunders; 2015. 17. Hoffbrand V, Provan D: ABC of clinical haematology: Macrocytic anaemias. BMJ 1997, 314(7078):430. 18. Lee JY, Choi H, Park JW, Son BR, Park JH, Jang LC, Lee JG: Age‐related changes in mean corpuscular volumes in patients without anaemia: An analysis of large‐volume data from a single institute. Journal of Cellular and Molecular Medicine 2022, 26(12):3548-3556. 19. Weiss G, Goodnough LT: Anemia of chronic disease. The New England Journal of Medicine 2005, 352(10):1011-1023. 20. Shah AR, Chaudhari SN, Shah MH: Role of platelet parameters in diagnosing various clinical conditions. National journal of medical research 2013, 3(02):162-165. 21. Beyan C, Kaptan K, Beyan E, Turan M: The platelet count/mean corpuscular hemoglobin ratio distinguishes combined iron and vitamin B 12 deficiency from uncomplicated iron deficiency. International journal of hematology 2005, 81:301-303. 22. Tefferi A, Hanson CA, Inwards DJ: How to interpret and pursue an abnormal complete blood cell count in adults. Mayo Clinic Proceedings 2005, 80(7):923-936. 23. Danon D, Bologna NB, Gavendo S: Memory performance of young and old subjects related to their erythrocyte characteristics. Experimental Gerontology 1992, 27(3):275-285. 24. Jaremo P, Milovanovic M, Nilsson S, Buller C, Post C, Winblad B: Alzheimer's disease is characterized by more low-density erythrocytes with increased volume and enhanced beta-amyloid x-40 content. Journal of Internal Medicine 2011, 270(5):489-492. 25. Chen SH, Bu XL, Jin WS, Shen LL, Wang J, Zhuang ZQ, Zhang T, Zeng F, Yao XQ, Zhou HD et al: Altered peripheral profile of blood cells in Alzheimer disease: A hospital-based case-control study. Medicine 2017, 96(21):e6843. 26. Milovanovic M, Nilsson S, Winblad B, Jelic V, Behbahani H, Shahnaz T, Oweling M, Jaremo P: Inverse relationship between erythrocyte size and platelet reactivity in elderly. Platelets 2017, 28(2):182-186. 27. Chen Y, Ma CN, Luo L, Yin J, Gao Z, Yu Z, Wan Z: The cross-sectional association between mean corpuscular volume level and cognitive function in Chinese over 45 years old: Evidence from the China Health and Retirement Longitudinal Study. PLoS One 2020, 15(12):e0243227. 28. Huang LT, Zhang CP, Wang YB, Wang JH: Association of Peripheral Blood Cell Profile With Alzheimer's Disease: A Meta-Analysis. Frontiers in Aging Neuroscience 2022, 14:888946. 29. Gamaldo AA, Ferrucci L, Rifkind J, Longo DL, Zonderman AB: Relationship between mean corpuscular volume and cognitive performance in older adults. J Am Geriatr Soc 2013, 61(1):84-89. 30. Qiang YX, Deng YT, Zhang YR, Wang HF, Zhang W, Dong Q, Feng JF, Cheng W, Yu JT: Associations of blood cell indices and anemia with risk of incident dementia: A prospective cohort study of 313,448 participants. Alzheimers Dement 2023. 31. Taniguchi Y, Shinkai S, Nishi M, Murayama H, Nofuji Y, Yoshida H, Fujiwara Y: Nutritional biomarkers and subsequent cognitive decline among community-dwelling older Japanese: a prospective study. J Gerontol A Biol Sci Med Sci 2014, 69(10):1276-1283. 32. Schneider AL, Jonassaint C, Sharrett AR, Mosley TH, Astor BC, Selvin E, Coresh J, Gottesman RF: Hemoglobin, Anemia, and Cognitive Function: The Atherosclerosis Risk in Communities Study. J Gerontol A Biol Sci Med Sci 2016, 71(6):772-779. 33. Qin T, Yan M, Fu Z, Song Y, Lu W, Fu A, Yin P: Association between anemia and cognitive decline among Chinese middle-aged and elderly: evidence from the China health and retirement longitudinal study. BMC Geriatr 2019, 19(1):305. 34. Faux NG, Rembach A, Wiley J, Ellis KA, Ames D, Fowler CJ, Martins RN, Pertile KK, Rumble RL, Trounson B et al: An anemia of Alzheimer's disease. Mol Psychiatry 2014, 19(11):1227-1234. 35. Ozturk ZA, Unal A, Yigiter R, Yesil Y, Kuyumcu ME, Neyal M, Kepekci Y: Is increased red cell distribution width (RDW) indicating the inflammation in Alzheimer's disease (AD)? Arch Gerontol Geriatr 2013, 56(1):50-54. 36. Beydoun MA, Hossain S, Beydoun HA, Shaked D, Weiss J, Evans MK, Zonderman AB: Red Cell Distribution Width Is Directly Associated with Poor Cognitive Performance among Nonanemic, Middle-Aged, Urban Adults. J Nutr 2020, 150(1):128-139. 37. Kim KM, Lui LY, Browner WS, Cauley JA, Ensrud KE, Kado DM, Orwoll ES, Schousboe JT, Cummings SR: Association Between Variation in Red Cell Size and Multiple Aging-Related Outcomes. J Gerontol A Biol Sci Med Sci 2021, 76(7):1288-1294. 38. Inestrosa NC, Alarcon R, Arriagada J, Donoso A, Alvarez J: Platelet of Alzheimer patients: increased counts and subnormal uptake and accumulation of [14C]5-hydroxytryptamine. Neurosci Lett 1993, 163(1):8-10. 39. Tsai CF, Lee WJ, Wang SJ, Shia BC, Nasreddine Z, Fuh JL: Psychometrics of the Montreal Cognitive Assessment (MoCA) and its subscales: validation of the Taiwanese version of the MoCA and an item response theory analysis. Int Psychogeriatr 2012, 24(4):651-658. 40. Lurie S, Gidron Y, Piper I, Ben-Aroya Z, Sadan O, Boaz M, Glezerman M: Memory performance in late pregnancy and erythrocyte indices. J Soc Gynecol Investig 2005, 12(4):293-296. 41. Norton JM: The effect of macrocytosis on rat erythrocyte deformability during recovery from phenylhydrazine-induced anemia. Biorheology 1990, 27(1):21-37. 42. Richards RS, Roberts TK, McGregor NR, Dunstan RH, Butt HL: The role of erythrocytes in the inactivation of free radicals. Med Hypotheses 1998, 50(5):363-367. 43. Droge W, Schipper HM: Oxidative stress and aberrant signaling in aging and cognitive decline. Aging Cell 2007, 6(3):361-370. 44. Lovell MA, Markesbery WR: Oxidative damage in mild cognitive impairment and early Alzheimer's disease. Journal of Neuroscience Research 2007, 85(14):3036-3040. 45. Torres LL, Quaglio NB, de Souza GT, Garcia RT, Dati LM, Moreira WL, Loureiro AP, de Souza-Talarico JN, Smid J, Porto CS et al: Peripheral oxidative stress biomarkers in mild cognitive impairment and Alzheimer's disease. J Alzheimers Dis 2011, 26(1):59-68. 46. Kosenko E, Tikhonova L, Alilova G, Urios A, Montoliu C: The Erythrocytic Hypothesis of Brain Energy Crisis in Sporadic Alzheimer Disease: Possible Consequences and Supporting Evidence. J Clin Med 2020, 9(1). 47. Mohanty JG, Eckley DM, Williamson JD, Launer LJ, Rifkind JM: Do red blood cell-beta-amyloid interactions alter oxygen delivery in Alzheimer's disease? Adv Exp Med Biol 2008, 614:29-35. 48. Mohanty JG, Shukla HD, Williamson JD, Launer LJ, Saxena S, Rifkind JM: Alterations in the red blood cell membrane proteome in alzheimer's subjects reflect disease-related changes and provide insight into altered cell morphology. Proteome Sci 2010, 8:11. 49. Chang CY, Liang HJ, Chow SY, Chen SM, Liu DZ: Hemorheological mechanisms in Alzheimer's disease. Microcirculation 2007, 14(6):627-634. | - |
dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/95096 | - |
dc.description.abstract | 研究背景及目標:平均紅血球體積是在血液常規檢查中常見的檢測項目,可以幫忙輔助貧血的診斷。平均較大的紅血球體積可能比較難以通過微血管、供應組織氧氣和營養素的能力較差,進而影響認知功能。高齡人口的認知功能障礙是近年重要的議題,過去僅有少數研究探討老年族群平均紅血球體積和認知功能障礙之間的關聯性,而且不同的研究間尚無一致的結果,因此本研究主要探討臺灣社區長者平均紅血球體積與認知功能隨時間變化之關聯。
研究方法:本研究是一項為期12年的前瞻性世代研究(2011-2022),自基線(2011-2013年)時納入530位年齡65歲以上之社區長者,每兩年追蹤一次,共追蹤四次,收集包含平均紅血球體積、血紅素、血小板、紅血球分佈寬度變異係數等血液常規檢查項目,每位受試者另收集血樣分析葉酸、維生素B12的濃度。使用蒙特利爾認知評估臺灣版評估長者的整體認知功能,另外也對記憶、注意力、語言流暢度及執行功能等四項認知功能領域進行評估。研究中使用廣義加成模型圖形的轉折點將平均紅血球體積分組,運用廣義線性混合模型分析長者平均紅血球體積與認知功能隨時間變化,並調整其他重要的因子(例如:年齡、性別、教育程度、血小板、紅血球體積分佈寬度變異係數、葉酸、維生素B12、載脂蛋白E ε4對偶基因帶原等)。 研究結果:受試者的平均年齡為72.7歲,其中女性占53.4%。隨著追蹤時間增加,基線時較大的平均紅血球體積 (平均紅血球體積>93.0 fL)與較差的邏輯記憶-立即回憶(β= -0.028,95% CI = -0.052至-0.004,p值0.021)、邏輯記憶-延遲回憶(β= -0.039,95% CI = -0.063至-0.014,p值0.002)邏輯記憶-延遲主題(β= -0.041,95% CI = -0.068至-0.013,p值0.003)、及注意力-順向記憶廣度評估(β= -0.028,95% CI = -0.052至-0.003,p值0.027)有關。我們同時發現平均紅血球體積與血小板之間在整體認知功能存在交互作用(pinteraction = 0.04)。 結論:平均紅血球體積隨者時間變化對多項認知功能領域會有負向的影響。平均紅血球體積可能可以成為評估認知障礙的早期指標,但是仍須更大型、更長期的研究以了解其中的時間關聯性與潛在機轉。 | zh_TW |
dc.description.abstract | Background
The mean corpuscular volume (MCV) is a common parameter in routine blood tests. Larger MCV tends to be more fragile and pose challenges in passing through capillaries, leading to a diminished capacity for oxygen and nutrient supply to the brain thus impacting cognitive function. Limited studies have explored the association between MCV and cognitive impairment with inconsistent results. This study aimed to investigate the association between MCV and cognitive function in community-dwelling older adults. Method This 12-year cohort study (2011-2022) included 530 non-demented older adults (aged above 65) from the ongoing Taiwan Initiative for Geriatric Epidemiological Research at baseline (2011 to 2013) with four biennial follow-ups. Global cognition was assessed by the Taiwanese version of the Montreal Cognitive Assessment. Domain-specific cognition, including memory, attention, verbal fluency, and executive function, was assessed by a battery of neuropsychiatric tests. Blood data were collected, including MCV, red blood cell distribution width, hemoglobin, platelet, and vitamin B12. The cutoff of MCV was determined by the turning point obtained from the generalized additive model. This study utilized a generalized linear mixed model to analyze the association between MCV and cognitive function adjusted for age, sex, years of education, apolipoprotein E ε4 status, years of follow-up, and other blood parameters. Result The average age of the participants is 72.7 years, with females comprising 53.40%. As the follow-up time increased, older adults with larger baseline MCV (>93.0 fL) exhibited a significantly poor performance of memory (immediate free recall: β= -0.028, p = 0.021; delayed free recall: β= -0.039, p = 0.002; delayed theme recall: β= -0.041, p = 0.003), and attention (digit span forward: β= -0.028, p = 0.027). Additionally, interactions were found between MCV and platelet on global cognition (pinteraction = 0.04). Conclusion Over time, increased MCV was associated with poor domain-specific cognition. MCV may potentially serve as an early indicator for assessing cognitive impairment. Larger and longer-term studies are needed to clarify their temporal relationship and underlying mechanism. | en |
dc.description.provenance | Submitted by admin ntu (admin@lib.ntu.edu.tw) on 2024-08-28T16:14:45Z No. of bitstreams: 0 | en |
dc.description.provenance | Made available in DSpace on 2024-08-28T16:14:45Z (GMT). No. of bitstreams: 0 | en |
dc.description.tableofcontents | 中文摘要 I
英文摘要 III 目次 V 圖次 VII 表次 VIII 第一章 導論 1 第二章 文獻回顧 3 第三章 研究缺口與假說 5 第四章 方法 6 第一節 研究設計 6 第二節 認知功能評估 6 第三節 血液樣本評估 7 第四節 共變項 7 第五節 統計分析 8 第五章 結果 9 第六章 討論 12 第七章 結論 16 參考文獻 42 附錄 46 | - |
dc.language.iso | zh_TW | - |
dc.title | 探討臺灣社區老人平均紅血球體積與認知功能之關聯 | zh_TW |
dc.title | Association Between Mean Corpuscular Volume and Cognitive Function in Community-Dwelling Older Adults | en |
dc.type | Thesis | - |
dc.date.schoolyear | 112-2 | - |
dc.description.degree | 碩士 | - |
dc.contributor.oralexamcommittee | 陳人豪;侯信安 | zh_TW |
dc.contributor.oralexamcommittee | Jen-Hau Chen;Hsin-An Hou | en |
dc.subject.keyword | 平均紅血球體積,認知功能,老年人, | zh_TW |
dc.subject.keyword | mean corpuscular volume,cognitive function,cognition,older adults, | en |
dc.relation.page | 46 | - |
dc.identifier.doi | 10.6342/NTU202401902 | - |
dc.rights.note | 未授權 | - |
dc.date.accepted | 2024-07-31 | - |
dc.contributor.author-college | 公共衛生學院 | - |
dc.contributor.author-dept | 公共衛生碩士學位學程 | - |
顯示於系所單位: | 公共衛生碩士學位學程 |
文件中的檔案:
檔案 | 大小 | 格式 | |
---|---|---|---|
ntu-112-2.pdf 目前未授權公開取用 | 2.51 MB | Adobe PDF |
系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。